BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36944483)

  • 1. Malodour from oral malignant fungating wound: sprayed metronidazole - case report.
    Harano H; Matsunuma R; Tanaka-Yagi Y; Ito M; Tasaki J; Egawa A; Yamaguchi T
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e966-e967. PubMed ID: 36944483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic antibiotics for treating malignant wounds.
    Ramasubbu DA; Smith V; Hayden F; Cronin P
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011609. PubMed ID: 28837757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of malodour and exudate in fungating wounds.
    Draper C
    Br J Nurs; 2005 Jun 9-22; 14(11):S4-12. PubMed ID: 15976610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical agents and dressings for fungating wounds.
    Adderley UJ; Holt IG
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD003948. PubMed ID: 24832784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving malodour management in advanced cancer: a 10-year retrospective study of topical, oral and maintenance metronidazole.
    George R; Prasoona TS; Kandasamy R; Cherian R; Celine T; Jeba J; Murali S; Mathew D
    BMJ Support Palliat Care; 2017 Sep; 7(3):286-291. PubMed ID: 28174164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical agents and dressings for fungating wounds.
    Adderley U; Smith R
    Cochrane Database Syst Rev; 2007 Apr; (2):CD003948. PubMed ID: 17443534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant fungating wounds: managing malodour and exudate.
    Alexander S
    J Wound Care; 2009 Sep; 18(9):374-82. PubMed ID: 19789474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyhexanide Versus Metronidazole for Odor Management in Malignant (Fungating) Wounds: A Double-Blinded, Randomized, Clinical Trial.
    Villela-Castro DL; Santos VLCG; Woo K
    J Wound Ostomy Continence Nurs; 2018; 45(5):413-418. PubMed ID: 30086103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of malodorous fungating malignant wounds on body image and quality of life.
    Young CV
    J Wound Care; 2005 Sep; 14(8):359-62. PubMed ID: 16178290
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Case study: eliminating odors from wounds.
    Poteete V
    Decubitus; 1993 Jul; 6(4):43-6. PubMed ID: 8297491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom burden and quality of life in patients with malignant fungating wounds.
    Lo SF; Hayter M; Hu WY; Tai CY; Hsu MY; Li YF
    J Adv Nurs; 2012 Jun; 68(6):1312-21. PubMed ID: 22043819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metronidazole gel in managing malodorous fungating wounds.
    Clark J
    Br J Nurs; 2002 Mar; 11(6 Suppl):S54-60. PubMed ID: 11979191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safe and effective deodorization of malodorous fungating tumors using topical metronidazole 0.75 % gel (GK567): a multicenter, open-label, phase III study (RDT.07.SRE.27013).
    Watanabe K; Shimo A; Tsugawa K; Tokuda Y; Yamauchi H; Miyai E; Takemura K; Ikoma A; Nakamura S
    Support Care Cancer; 2016 Jun; 24(6):2583-90. PubMed ID: 26715293
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metrotop: a topical antimicrobial agent for malodorous wounds.
    Moody M
    Br J Nurs; 1998 Mar 12-25; 7(5):286-9. PubMed ID: 9616550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malignant wound management in advanced illness: new insights.
    Grocott P; Gethin G; Probst S
    Curr Opin Support Palliat Care; 2013 Mar; 7(1):101-5. PubMed ID: 23254858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intervention for symptom management in patients with malignant fungating wounds - a systematic review.
    Tsichlakidou A; Govina O; Vasilopoulos G; Kavga A; Vastardi M; Kalemikerakis I
    J BUON; 2019; 24(3):1301-1308. PubMed ID: 31424694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Eliminating odors associated with necrotic lesions.
    O'Rourke ME
    Oncol Nurs Forum; 1991; 18(1):134. PubMed ID: 2003109
    [No Abstract]   [Full Text] [Related]  

  • 18. Topical metronidazole. Part II.
    McMullen D
    Ostomy Wound Manage; 1992 Apr; 38(3):42-6, 48. PubMed ID: 1580972
    [No Abstract]   [Full Text] [Related]  

  • 19. A topical metronidazole gel used to treat malodorous wounds.
    Bale S; Tebbie N; Price P
    Br J Nurs; 2004 Jun; 13(11):S4-11. PubMed ID: 15218439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A palliative approach to the management of malodour from malignant fungating tumours.
    West D
    Int J Palliat Nurs; 2007 Mar; 13(3):137-42. PubMed ID: 17505407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.